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SUMMARY
Embryonic stem cells (ESCs) repress the expression of exogenous proviruses and endogenous 
retroviruses (ERVs). Here, we systematically dissected the cellular factors involved in provirus 
repression in embryonic carcinomas (ECs) and ESCs by a genome-wide siRNA screen. Histone 
chaperones (Chaf1a/b), sumoylation factors (Sumo2/Ube2i/Sae1/Uba2/Senp6), and chromatin 
modifiers (Trim28/Eset/At-f7ip) are key determinants that establish provirus silencing. RNA-seq 
analysis uncovered the roles of Chaf1a/b and sumoylation modifiers in the repression of ERVs. 
ChIP-seq analysis demonstrates direct recruitment of Chaf1a and Sumo2 to ERVs. Chaf1a 
reinforces transcriptional repression via its interaction with members of the NuRD complex 
(Kdm1a, Hdac1/2) and Eset, while Sumo2 orchestrates the provirus repressive function of the 
canonical Zfp809/Trim28/Eset machinery by sumoylation of Trim28. Our study reports a genome-
wide atlas of functional nodes that mediate proviral silencing in ESCs and illuminates the 
comprehensive, interconnected, and multi-layered genetic and epigenetic mechanisms by which 
ESCs repress retroviruses within the genome.
Graphical abstract
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INTRODUCTION
The expression of proviruses and endogenous retroviruses (ERVs) is restricted in pluripotent 
stem cells (Feuer et al., 1989; Niwa et al., 1983; Teich et al., 1977). This silencing has likely 
evolved for the protection of germline cells from insertional mutagenesis (Gaudet et al., 
2004; Walsh et al., 1998). The expression and DNA methylation profiles of the Moloney 
murine leukemia virus (MMLV) have been investigated in embryonic carcinoma cells (ECs) 
and embryonic stem cells (ESCs) (Niwa et al., 1983). DNA methylation is thought to repress 
the expression of viral genes in differentiated cells, while repression in pluripotent cells is 
mediated by both cis-acting de novo methylation of the integrated proviruses (Gaudet et al., 
2004; Walsh et al., 1998) and trans-acting transcriptional repressors (Petersen et al., 1991; 
Stewart et al., 1982; Walsh et al., 1998; Wolf et al., 2008a; Wolf and Goff, 2007).
It has been reported that many ERVs affect cellular gene activity by acting as alternative 
promoters or enhancers (Peaston et al., 2004). For example, MERVL is transiently activated 
during the mouse two-cell (2C) stage, regulating the expression of 2C-specific genes 
(Macfarlan et al., 2012). ERVs may also function in the reprogramming of somatic cells into 
induced pluripotent stem cells (iPSCs). Specific ERVs are re-activated during the 
reprogramming process, while other classes of ERVs have to be silenced to attain complete 
reprogramming (Friedli et al., 2014; Wissing et al., 2012). Together, these studies suggest 
that proviral silencing is a characteristic of the pluripotent state, and the precise expression 
of ERVs have critical roles during embryogenesis and development.
Various studies have implicated diverse epigenetic mechanisms in the silencing of 
retroviruses and ERVs. Repression is thought to be dependent on a conserved sequence 
element termed the primer binding site (PBS). Factors such as Zfp809, Trim28, and Eset are 
responsible for mediating the H3K9me3 repressive silencing mechanism (Friedli et al., 
2014; Rowe et al., 2010; Wolf and Goff, 2007, 2009; Wolf et al., 2008b). Eset was shown to 
be involved in the repression of retroviruses and subfamilies of ERVs, predominantly of 
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class I and II ERVs (Karimi et al., 2011; Matsui et al., 2010). More recently, viral-silencing 
factors such as the zinc finger protein Yin yang 1 (Yy1), Erb3 binding protein 1 (Ebp1), and 
the polycomb repressive complex 2 (PRC2) catalytic subunit Ezh2 (Schlesinger et al., 2013; 
Schlesinger and Goff, 2013; Wang et al., 2014) have been described. Other studies reporting 
the role of host factors governing ERVs in model organisms, such as Saccharomyces 
cerevisiae (Maxwell and Curcio, 2007) have also provided critical evolutionary insight into 
the dynamics of retroviral regulation.
Despite many efforts to identify the factors involved, many components of the epigenetic 
machinery required for stable silencing of proviruses and ERVs remains poorly 
characterized. To advance our understanding, we developed a powerful high-throughput 
screening approach based on a provirus MMLV-Gfp reporter (Schlesinger et al., 2013) and 
genome-wide small interfering RNA (siRNA) knockdown. Our screen identified 303 
determinants of viral silencing in mouse ESCs with high confidence and provides a genome-
wide functional interrogation of determinants mediating proviral silencing in pluripotent 
embryonic stem cells.
RESULTS
Unbiased Genome-wide siRNA Screen for Determinants of Proviral Silencing in Embryonic 
Carcinoma Cells
To define the factors involved in the silencing process, we developed a high-throughput 
screening approach based on a provirus MMLV-Gfp reporter and siRNA knockdown in F9 
ECs (Figure 1A). F9 cells were infected with the MMLV-Gfp virus and then reverse 
transfected with siRNA in 384-well plates. Expression of Gfp on day 4 post-infection 
indicated retrovirus activation.
We first confirmed the sensitivity of the reporter assay via knockdown of canonical 
repressive genes Trim28 and Eset. Consistently, imaging, and fluorescence-activated cell 
sorting (FACS) analysis showed that knockdown of both factors dramatically relieved the 
repression of retroviral Gfp (Figures S1A and S1B). We next carried out a pilot screen on 
the kinome siRNA library in F9 cells, using non-targeting (siNT) Trim28 and Eset siRNAs 
as controls. The kinome library screen was analyzed by Z-prime score (Figures S1C–S1F). 
From the screen, we identified both known (Trim28 and Cdk9) and undetermined factors 
(Chuk, Epha4, Csnk1e, Sgpp1, and Npp4a) responsible for retrovirus silencing (Figure 
S1G). Cdk9 was previously reported to interact with HIV-1 Tat protein and regulate HIV-1 
transcription (Kao et al., 1987).
Next, we carried out a whole genome siRNA screen targeting 20,000 genes in F9 cells 
(Figure 1A). Candidates that caused excessive cell death upon siRNA knockdown were 
excluded using a stringent nuclei number cut-off threshold. Based on the normalized Gfp 
signal cut-off value, which short-listed factors that had values larger than 2 SDs from the 
mean of the negative controls (Figure 1B), 650 factors were short-listed (Table S1). Among 
the hits are factors previously implicated in retroviral silencing process, such as Eset, 
Zfp809, Yy1, and Trim28. In addition, new candidates identified include Ube2i, Pcna, 
Hist1h3c, Mphosph8, Adcy6, Sh3bp1, and Thyn1 (Figure 1C).
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To validate the genome-wide siRNA screen, we performed secondary siRNA screens 
utilizing the MMLV-Gfp reporter and an independent MMLV-mCherry reporter. We 
observed strong correlation between the two reporters (Figure 1D). To minimize possible 
non-specific effects from the pooled siRNA, we designed two pairs of short hairpin RNAs 
(shRNAs) for 31 candidate genes and three non-candidate genes. shRNA validation was 
performed in F9 cells, followed by FACS analysis of Gfp expression. shRNA knockdown 
efficiencies were confirmed by qPCR (Figure S1H) and western blot analysis for selected 
genes (Figure S1I). Notably, we observed robust Gfp reactivation for the majority of top hits 
(Figure 1E). From the results of secondary siRNA and shRNA screens, we focused on the 
top 303 hits that were highly corroborative with the primary screen and are considered high 
confidence candidates.
Network Analysis of the Candidates Reveals Multiple Interacting Pathways Involved in 
Proviral Silencing
We performed Gene Ontology (GO), KEGG, and Interpro analysis (Huang et al., 2009) on 
the top 303 hits and elucidated 148 statistically enriched biological processes and pathways, 
including chromatin modification and organization, protein sumoylation and 
phosphorylation, regulation of transcription, DNA replication, DNA repair, and methylation 
(Figure S2A; Table S2). Protein-protein interaction analysis of the high confidence hits 
demonstrates tight and dense interaction between the candidate proteins (Figure 2A). In 
addition, cellular component analysis revealed that the candidates were widely distributed in 
different sub-cellular fractions (Figures 2A and S2B). These suggest that proviral silencing 
is controlled by multilayered machineries involving components of different cellular 
pathways and with varied cellular localization.
Candidate Genes Are Potent Repressors of Provirus Expression in Embryonic Stem Cells
We analyzed the expression profiles of the candidate genes in over 100 cell lines using the 
cTen database (Shoemaker et al., 2012). The majority of candidate genes are highly 
expressed in embryonic stem cell lines and are low in other tissue-specific cell lines (Figure 
S2C). The expression of selected candidates was further tested in the mouse ESC lines E14 
and D3, mouse EC lines F9 and P19, as well as in differentiated mouse embryo fibroblasts 
(MEFs). Consistent with cTen enrichment scores, qPCR analyses showed embryonal and 
stem cell-specific expression of the candidates (Figure S2D).
To further interrogate the function of our candidate hits, we performed network analysis of 
the hits based on their tiered ranking. We observed greater interactions among our top 50 
candidates, although the lower ranked hits also exhibited specific interactions indicative of 
their biological significances (Figure 2B). Among the top 20 hits are the histone chaperones 
(Chaf1a/b), sumoylation modification genes (Ube2i, Sumo2, Uba2, Sae1, and Senp6), and 
chromatin-bound factors (Eset, Atf7ip, Zfp809, Trim28). To test the functional specificity of 
these strong candidates in mESCs, we conducted siRNA and shRNA knockdowns in two 
mESC lines E14 and D3 and in two differentiated cell types, 3T3 and MEFs. The results of 
the Gfp reporter rescue assay from mESC lines corroborate well with the primary screen 
done in F9 cells (Figures 2C, 2D, and S2E). In contrast, MMLV-driven expression of Gfp or 
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mCherry was high in 3T3 and MEFs at the outset and knockdown of candidate genes did not 
result in perturbations of the reporter signal in these cell lines (Figures 2E and S2F).
To further assess the ESC specificity of our candidates, we differentiated E14 and D3 cells 
via embryoid body (EB) formation and neural differentiation (Ying et al., 2003). The 
differentiated cells lost their ESC-specific morphologies and pluripotency markers and 
expressed high levels of differentiation genes (Figures 2F and S2G). Consistent with a 
previous report, the MMLV virus remain silenced in differentiated ESCs (Niwa et al., 1983). 
None of the candidate gene knockdowns in the differentiated cells could rescue MMLV-Gfp 
reporter expression (Figures 2G and S2H), suggesting that alternative or additional silencing 
pathways are active in these cells. Relative copy number of integrated reporters in E14 and 
the differentiated cells was indistinguishable, ruling out the possibility of reduced viral 
integration in the latter (Figures S2I and S2J). In addition, knockdown of the top hits did not 
reduce provirus integration efficiency in E14 cells (Figure S2K). Of note, we observed no 
significant change in Gfp signal driven by an integrated non-LTR reporter (PiggyBac-CAG-
Gfp) upon knockdown of the top hits (Figures S2L and S2M). This strongly suggests that the 
mode of proviral regulation by the factors is transcriptional or epigenetic.
Chaf1a/b and Sumoylation Modification Complex Play Critical Roles in Regulating ERVs
To evaluate the roles of Chaf1a/b and the sumoylation factors in ERV regulation, we 
measured ERV expression by qPCR upon depletion of the candidates. Consistent with a 
previous study, Trim28 knockdown elicited reactivation of IAP elements in ESCs (Figure 
S3A) (Rowe et al., 2010). Intriguingly, we found up-regulation of class I (GLN), class II 
(MMERVK10c), and class III (MERVL) elements following depletion of the factors from 
the Caf1 complex, sumoylation complex, and Atf7ip (Figure S3A). Notably, Northern blot 
assays confirmed increased transcription of MERVL, but not of IAP and MusD elements in 
Chaf1a/b depleted E14 cells (Figure S3C). Meanwhile, knockdown of selected weaker 
candidates also showed consistent de-repression of MERVL but not of the other ERVs 
(Figure S3B).
To further delineate the regulatory roles of the candidates on ERVs, we performed genome-
wide RNA sequencing (RNA-seq) of Chaf1a/b-, Sumo2-, Sae1-, Ube2i-, Ube2-, Senp6-, 
Trim28-, Eset-, and Atf7ip-depleted cells. Transcriptomic analyses revealed significant de-
repression of several families of ERVs upon depletion of each factor (Figure 3A; Table S3). 
In contrast to their effects on global gene expression (Figure S3D), the majority of the ERV 
targets are upregulated upon shRNA knockdown (Figure 3B). Together, these suggest an 
ERV-specific repressive function of the candidates.
Next, we evaluated the ERV classes regulated by the candidates. Chaf1a/b depletion resulted 
in the de-repression of large numbers of Class III ERVs, while the sumoylation and 
canonical factors regulated more Class II ERVs (Figure 3C). Cluster analysis detected strong 
correlation of ERV regulation within the Chaf1a/b, sumoylation factors, and the chromatin 
binding factors Trim28, Atf7ip, and Eset (Figure 3D), whereas the analysis of global gene 
expression displayed a different pattern (Figure S3E).
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Remarkably, Trim28 shares significant similarity with both the Chaf1a/b and sumoylation 
factors in their ERV regulation (Figure 3D), suggesting overlapping mechanisms. ERVs 
controlled by Atf7ip overlapped extensively with the ones regulated by Trim28 or Eset 
(Figure S3F), indicating that Atf7ip may be integral to the canonical Krab-Zfp/Trim28/Eset 
machinery. Atf7ip was shown to be a co-factor of Eset that helps in facilitating the 
conversion of H3K9me2 to H3K9me3 (De Graeve et al., 2000; Wang et al., 2003). 
Furthermore, the ERVs regulated by Chaf1a overlaps significantly with the ones regulated 
by Chaf1b (Figures 3D, 3E and 3G), but differ significantly from those controlled by Sumo2 
(Figures 3F and 3H). One key feature of the cluster of sumoylation genes is the strong 
correlation between the factors in the specific control of their ERV targets as shown by the 
tight pairwise correlation (Figure 3E). This suggests a coordinated mechanism involving 
multiple members of the same sumoylation pathway. Interestingly, most ERVs regulated by 
Sae1 and Ube2i are part of the larger number of ERVs governed by Sumo2, suggesting a 
central role for Sumo2 in this sumoylation process (Figure 3G). It is noteworthy that many 
ERVs regulated by Sumo2 are similarly governed by Trim28 (Figures 3F and 3H).
To validate the RNA-seq data, we performed qPCR on each class of ERVs (Figure S3G). 
Consistently, RLTR6_Mm/ERV1 was specifically regulated by the sumoylation factors, 
while ET-nERV3-int/ERVK was regulated by Atf7ip, Eset, and Chaf1a, but not by the 
sumoylation factors. MT2_Mm/ERVL was sharply upregulated upon the depletion of 
Chaf1a/b, while expression was less perturbed with depletion of factors from the other two 
clusters. Finally, LTR16D was upregulated upon depletion of genes from all the clusters.
Chaf1a and Sumo2 Are Directly Recruited to ERVs
We wanted to determine whether Chaf1a and Sumo2 are enriched on genomic ERVs. First, 
we introduced 3xHA tags at the 3′end of the endogenous Chaf1a locus in F9 cells using 
CRISPR/Cas technology (Figure S4A). The Chaf1a-3xHA cell line was characterized by 
shRNA knockdown, which led to the specific reduction of Chaf1a-3xHA as measured by 
western blot and immunostaining (Figure S4B). In addition, a Zfp809-3xHA overexpression 
D3 cell line was also established and similarly characterized (Figure S4C). The reliability of 
the Sumo2 antibodies used for chromatin immunoprecipitation (ChIP) was confirmed with 
knockdown of Sumo2 followed by western blot analysis (Figure S4D). To survey the global 
binding profiles of Chaf1a, Sumo2, Trim28, and Zfp809 on genomic ERV loci, we 
performed ChIP sequencing (ChIP-seq). The quality of the ChIP DNA was determined by 
qPCR and motif analysis. Zfp809-3xHA ChIP-qPCR yielded high enrichment at proline 
PBS site (Figures S4E and S4F), and Trim28 ChIP-qPCR showed strong binding at a 
previously reported target gene Ptpn18 (Figure S4G) (Hu et al., 2009).
ChIP-seq analysis revealed that both Chaf1a and Sumo2 are recruited to loci of members of 
several classes of ERVs (Figures 4A and 4B; Table S4). We next asked if the bound ERV 
loci are enriched for any histone modifications. We compared the Chaf1a, Sumo2, Trim28, 
and Zfp809 ChIP-seq data with publicly available datasets of histone marks and Eset ChIP-
seq. Although the majority of ERVs bound by Chaf1a are enriched with H3K9me3 (Figure 
4C), the H3K9me3 is of lower intensity compared to that of Trim28, Zfp809, and Sumo2 
bound ERVs (Figure 4C). Intriguingly, considerable proportions (15%) of Chaf1a bound 
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ERVs are also enriched for the active H3K4me3 modification (Figure 4C). Furthermore, 
Chaf1a-bound ERVs exhibit higher levels of H3K4me2 and H3K9Ac (Figure S4H). This 
raises the possibility that additional accessory proteins may be required for Chaf1a to exert 
the silencing effects. Notably, Sumo2-targeted ERV loci are associated with elevated 
H3K9me3 levels and reduced levels of H3K4me3 modification. This binding pattern 
strongly resembles that of Zfp809 and Trim28 (Figure 4C). In contrast, the non-ERV loci 
bound by Chaf1a were enriched with abundant H3K4me3 marks and had no trace of 
H3K9me3 modifications. On the other hand, Sumo2/Trim28/Zfp809-bound loci exhibit 
detectable but low levels of H3K9me3 (Figure 4D). Collectively, this indicates differing 
modes of regulation by which individual factors control ERVs and non-ERV targets 
(Figures 4C, 4D, and S3C).
To determine the action of Chaf1a and Sumo2, we represented ERV loci bound by these 
factors in Venn diagrams. We found that Trim28 binds 56% of Chaf1a-bound sites, while 
57% of Chaf1a ERVs are also targets of Sumo2 (Figure 4E). Moreover, only 31% of Chaf1a 
ERV loci are enriched for Zfp809 (Figure S4I). In contrast, 77% of Trim28 targets and 73% 
of Eset-bound ERVs are accompanied by enrichment of Sumo2 (Figures 4E and S4I). When 
we extend the analysis to three factors, we observed that more than 80% of Chaf1a/Trim28 
and Chaf1a/Eset common targets have Sumo2 binding (Figure 4F). These observations 
strongly suggest a possible role of Sumo2 in Trim28/Eset ERV regulation. The co-regulation 
of Chaf1a and Sumo2 with the canonical Zfp809/Trim28/Eset machinery seems to be ERV-
specific as very little overlap was observed between the factors on non-ERV loci (Figure 
S4J). Collectively, in terms of ERV regulation, Chaf1a binding is clustered away from the 
Sumo/Zfp809/Trim28/Eset axis (Figures 4G, 4H, and S4K). This is remarkably similar to 
the pattern observed from the RNA-seq data (Figure 3D). Overall, our ChIP data provides 
the first biochemical demonstration that a histone chaperone and a sumoylation modification 
protein can exert direct regulation of genomic ERVs.
Sumo2 Orchestrates the Viral Silencing Activities of Trim28 through Its Sumoylation 
Modification
Our genome-wide siRNA screen identified Sumo2, and not Sumo1 or Sumo3, to have a 
distinct role in proviral silencing (Figures S5A–S5C). The global RNA-seq and ChIP-seq 
data further suggest that Sumo2 may repress proviruses and ERVs through modulation of 
the Trim28/Eset machinery (Figure 5A). To test this possibility, we first performed Sumo2 
ChIP-qPCR and identified its binding on the proviral LTR. Importantly, when Trim28 was 
knocked-down, the level of Sumo2 binding on both proviral elements and most of the ERVs 
tested was drastically reduced (Figures 5B and 5C). In contrast, enrichment of Sumo2 was 
not affected by Chaf1a knockdown (Figures S5D and S5E). Furthermore, the removal of 
Sumo2 abolished the binding of Trim28 at the LTR (Figure 5D).
To interrogate whether Sumo2 directly targets Trim28 for sumoylation, we studied well 
characterized 3xFlag-Sumo2 E14 cells generated using CRISPR/Cas technology (Figures 
S5F–S5I). Notably, we identified Trim28 in the pull-down of sumoylated proteins (Figure 
5E).
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Venn diagram analysis of ChIP-seq data indicates that ~90% of Sumo2/Trim28-bound ERV 
sites are marked with H3K9me3 modifications (Figure 5F). Trim28 is known to mediate the 
recruitment of Eset, which in turn deposits the repressive H3K9me3 mark at the proviral 
LTR (Matsui et al., 2010). Consistently, Sumo2 knockdown resulted in concomitant 
reduction in H3K9me3 marks and elevation of H3K4me3 modifications at the proviral 
elements and ERVs to levels that are comparable with that seen upon Trim28 knockdown 
(Figures 5G–5I).
Chaf1a Has Differential Regulatory Roles on Class I, II, and III ERVs
Venn diagram analysis on ERVs bound by Chaf1a, Trim28, and those associated with the 
H3K9me3 modification revealed that about 64% of ERVs co-bound by Chaf1a and Trim28 
are enriched with H3K9me3 (Figure 6A). In comparison, only 23% of Chaf1a/Trim28 
bound non-ERV loci are marked with H3K9me3 (Figure S6A). This concurs with the notion 
that Chaf1a and Trim28 exert ERV-specific repressive functions. In particular, there are 
significant numbers of ERVs co-bound by Chaf1a and Trim28, or exclusively bound by 
Chaf1a that are not marked with H3K9me3, suggesting that Chaf1a may adopt alternative 
repressive mechanisms on these ERVs. To this end, we classified the ERVs into four 
categories, namely, those bound by Chaf1a+Trim28+H3K9me3, Chaf1a+Trim28, Chaf1a 
only, and Trim28 only (Table S5). Interestingly, the Chaf1a only category has the highest 
percentage of class III ERVs (Figure 6B), while the Chaf1a+Trim28+H3K9me3 category 
primarily belong to class I and class II ERVs (Figure 6B). Consequentially, the dot plots 
(Figures 6C and S6B) correlating ERV upregulation and the enrichment of histone marks 
further highlighted the low levels of H3K9me3 on Chaf1a-regulated class III ERVs.
Specific class III ERVs are highly expressed in early embryonic development and 
downregulated at the morula and blastula stages. Histone demethylase Kdm1a (Macfarlan et 
al., 2012) and H3K9 dimethyl transferase G9a are the key epigenetic regulators of these 
ERVs (Leung et al., 2011; Maksakova et al., 2013). It was found that Kdm1a and histone 
deacetylase Hdac1/2 cooperatively contribute to transcriptional silencing (Shi et al., 2004). 
Hdacs have been shown to repress MERVL in concert with Kdm1a in pluripotent stem cells 
(Macfarlan et al., 2011; Reichmann et al., 2012). Interestingly, Kdm1a is one of the 
candidate hits in our siRNA screen (Table S1). To further dissect the mode of ERV 
regulation within each of the four categories, we integrated our Chaf1a and Trim28 ChIP-
seq data with datasets for epigenetic factors, such as Kdm1a and Hdac1/2. Surprisingly, the 
ERVs from the Chaf1a only category display the highest enrichment of Kdm1a and Hdac1/2 
in comparison to the other categories (Figures 6D and 6E). In contrast, the ERVs bound by 
Chaf1a+Trim28+H3K9me3 exhibit low levels of Kdm1a and Hdac1/2 binding (Figures 6D–
6F and S6D). Consistently, the Chaf1a only category is characterized by significantly higher 
levels of H3K4me2, H3K9Ac, and H3K27Ac marks, which are the substrates of Kdm1a and 
Hdacs, respectively (Figures 6D and S6C). We further performed ERV expression analysis 
using a published mESC Kdm1a knockdown RNA-seq dataset (Agarwal et al., 2015). 
Kdm1a knockdown resulted in mostly class I and III ERV upregulation, in a manner similar 
to Chaf1a knockdown (Figure S6E). In terms of ERVs regulated, Kdm1a/Chaf1a 
knockdown has 80% more overlap than Kdm1a/Trim28 knockdown (Figures S6F and S6G). 
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Overall, our data indicates that Chaf1a regulates class I, II, and III ERVs through vastly 
different mechanisms, which may depend on the co-regulators.
Chaf1a Represses Proviruses through Epigenetic Co-factors
Chaf1a is the core component of the chromatin assembling factor complex (Caf1) that also 
includes Rbbp4. Interestingly, only Chaf1a/b exhibited a proviral silencing function, while 
the knockdown of Rbbp4 had no effect (Figures S7A and S7B). Moreover, our siRNA 
screen did not uncover other histone chaperones necessary for retroviral silencing, further 
highlighting the specificity of Chaf1a/b in this process (Figure S7B). To further delineate the 
function of Chaf1a, we performed a pull-down of Flag-tagged Chaf1a followed by stable 
isotope labeling using amino acids (SILAC)-based quantitative mass spectrometry (MS) 
analysis (Figure 7A). The complete list of Chaf1a-interacting proteins includes several 
known and unknown factors (Figure 7A; Table S6). Chaf1a has previously been shown to 
interact with chromatin modifying factors (Quivy et al., 2004; Sarraf and Stancheva, 2004). 
Indeed, we identified several epigenetic modifiers that appeared in both the Chaf1a MS and 
genome-wide siRNA screen list, such as Kdm1a, Smarcc1, and Eset. Using co-
immunoprecipitation (coIP), we confirmed the interaction of Chaf1a with histone 
methyltransferase Eset, histone de-methylase Kdm1a, deacetylase Hdac2, and histone 
chaperones Chaf1b (Figures 7B–7D, S7C, and S7D).
To investigate the direct effects of Chaf1a at provirus loci, we used the Chaf1a-3xHA 
CRISPR F9 cell line for ChIP-qPCR analysis. We observed direct localization of Chaf1a to 
the proviral LTR elements (Figure 7E), which was further confirmed by Chaf1a-V5 ChIP 
(Figure S7E). To address the relationship between Chaf1a and Trim28, we performed ChIP 
on Trim28 upon Chaf1a knockdown. The binding of Trim28 was significantly abolished by 
the knockdown of Trim28 itself, whereas Chaf1a-knockdown elicited no effect (Figure S7F). 
This suggests that Trim28 recruitment to the provirus is independent of Chaf1a. Moreover, 
we did not detect any change in Chaf1a enrichment upon Sumo2 depletion (Figure S7G).
To understand the mechanisms by which Chaf1a silences the newly introduced proviruses, 
we performed ChIP on the Chaf1a interacting histone modifiers Kdm1a and Hdac2. To our 
surprise, both Kdm1a and Hdac2 were enriched at the proviral LTR (Figures 7F and 7G). In 
addition, consistent with the siRNA screen, shRNA knockdown of Kdm1a was able to 
rescue the expression of MMLV-Gfp reporter (Figure S7H). Treatment of E14 cells using 
the Hdac inhibitor TSA also relieved silencing of the MMLV-Gfp reporter (Figure S7I). 
Next, we tested the dynamic changes of the histone marks on the provirus LTR and ERVs 
upon the depletion of Chaf1a. The enrichment of H3K9me3 on provirus LTR was slightly 
reduced (Figure 7H), while the active H3K4me3 and total H3Ac marks were significantly 
increased (Figures 7I, 7J, and S7J–S7L). Together, our data shows that the repressive 
function of Chaf1a on proviruses is reinforced by the presence of its interacting partners, 
Kdm1a, Hdac2, and Eset.
To test whether Chaf1a can directly bind the viral DNA, we performed electrophoretic 
mobility shift assays (EMSA). We did not observe a specific EMSA band for the Chaf1a 
protein, indicating that Chaf1a does not bind directly to the viral DNA (Figures S7M–S7O). 
The Caf1 complex is thought to assemble histones H3/H4 during DNA replication and repair 
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(Gaillard et al., 1996; Kaufman et al., 1995). Other studies have indicated that histone 
chaperones Asf1a/b work synergistically with Caf1 (Tyler et al., 1999). Our proteomics data 
also identified Asf1a/b as components of the Chaf1a interactome (Figure 7A), and the 
interaction between Chaf1a and Asf1a/b was confirmed by coIP (Figure S7P). To further 
test the function of histone assembly on proviral silencing, we performed single and 
combinatorial shRNA knockdown of Asf1a/b. Surprisingly, combinatorial depletion of 
Asf1a/b induced strong Gfp reactivation to a level comparable to that observed following 
Chaf1a depletion (Figure S7Q), indicating functional redundancy between Asf1a and Asf1b. 
This data substantiates a possible role of histone assembly in the silencing of proviral 
elements and ERVs.
DISCUSSION
Mammalian genomes are cluttered with endogenous viral elements, vestiges of the long 
history of coevolution with retrotransposons that have shaped the genome. Complex 
mechanisms have evolved to manage these elements, restricting their expression and 
reactivation. Silencing of retroviruses also played a fortuitous role in the development of 
somatic cell reprogramming by transcription factors, as extinction of the reprogramming 
transgenes that occurs when fibroblasts revert to a pluripotent state is essential for the 
induced pluripotent stem cells to avoid oncogenic transformation and manifest their multi-
lineage differentiation potential (Takahashi and Yamanaka, 2006). Our work provides 
insights into the role of the histone chaperone Chaf1a and sumoylation factor Sumo2 in the 
silencing of exogenous proviruses and ERVs. It supports a model where Chaf1a promote the 
deposition of histone H3/H4, thus marking the integrated proviral DNA for silencing, 
helping to localize the Chaf1a protein to the viral LTR region (Figure 7K). The binding and 
transcriptional repression of the proviral chromatin by Chaf1a is further reinforced via the 
enzymatic activities of Chaf1a-interacting proteins Eset, Kdm1a, and Hdac1/2, which 
modify proviral chromatin with the repressive histone mark H3K9me3 and reduce the 
acquisition of activating H3K4me3 and H3Ac marks (Figure 7K). In parallel, Sumo2 is 
required to play critical roles in the canonical Zfp809/Trim28/Eset complex via post-
translational sumoylation of Trim28. Sumoylation enhances the recruitment of Trim28 to the 
proviral DNA, which in turn results in the modification of proviral chromatin with 
repressive histone H3K9me3 marks (Figure 7K). Our unbiased screen for factors involved in 
proviral silencing has thus revealed a complex set of genetic and epigenetic mechanisms by 
which exogenous proviruses and ERVs are transcriptionally silenced in pluripotent stem 
cells.
Cross-Talk between the Sumoylation Pathway and the Canonical Complex
Among the Sumo2-related candidates, Senp6 deconjugates Sumo2 from targeted proteins 
(Mukhopadhyay and Dasso, 2007), while the other factors are involved in covalent 
attachment of Sumo2 to the targeted proteins (Desterro et al., 1999; Geiss-Friedlander and 
Melchior, 2007; Gong et al., 1999; Hay, 2005; Johnson, 2004; Zhao, 2007). As such, it is 
tempting to speculate that the modification of key determinants by sumoylation or de-
sumoylation may affect their capacity to silent the proviruses and ERVs. The cross-talk 
between chromatin modifying complex subunits (such as Trim28, Atf7ip, and Eset) and 
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sumoylation factors can be inferred from the overlap of target ERVs observed, as well as 
their close protein-protein interactions. Importantly, our study clarifies the mechanism by 
which Sumo2 targets the proviral elements and ERVs—through the sumoylation of Trim28. 
Furthermore, Sumo modification on other epigenetic factors may potentially help mediate 
heterochromatin formation. It will be of great interest to determine the proteome-wide set of 
sumoylated proteins in ESCs.
Regulation of Different Classes of ERVs
Our RNA-seq analysis indicates that Chaf1a/b and sumoylation factors regulate different 
families of ERVs. Localization of Chaf1a and Sumo2 at ERV loci was confirmed by ChIP-
seq analysis. It is noteworthy that the pattern of the ERVs regulated by Chaf1a is distinct 
from that of the sumoylation machinery or chromatin-modifying factors (Trim28, Eset, and 
Zfp809). Interestingly, Chaf1a regulates a significant number of ERVs from class III that are 
not marked with H3K9me3, but instead are enriched for H3K4me2 and H3K27Ac. 
Moreover, Chaf1a works with the enzymatic epigenetic modifiers, including Kdm1a and 
Hdac2 at these class III ERVs. In addition, Chaf1a also cooperates with Trim28 to repress 
the ERVs by reinforcing high levels of the H3K9me3 on class I and II ERVs. Thus, our 
study highlights how a chaperone like Chaf1a regulates different classes of ERVs through 
distinct interacting co-factors.
Suppressive Function of Histone Chaperone Chaf1a/b on Newly Integrated Proviruses
Caf1 has been reported to have diverse functions, including epigenetic regulation, DNA 
damage repair, and DNA replication (Green and Almouzni, 2003; Kaufman et al., 1995; 
Poleshko et al., 2010; Shibahara and Stillman, 1999). More recently, Chaf1a was shown to 
be critical for maintaining the heterochromatin state through its interaction with HP1, 
MBD1, and Eset (Murzina et al., 1999; Reese et al., 2003; Sarraf and Stancheva, 2004). In 
fact, protein structure analysis of Chaf1a indicates a PXVXL pentapeptide motif at the N 
terminus, which allows Chaf1a to specifically interact with the HP1 chromo shadow domain 
(Thiru et al., 2004). Stable association of Chaf1a with HP1 proteins may lead to its retention 
in heterochromatin (Murzina et al., 1999). HP1 proteins are “readers” of repressive 
H3K9me3 marks and interact extensively with Eset. Intriguingly, our proteomics identified 
Eset, HP1α, HP1β, and HP1γ among the Chaf1a interactome. Remarkably, only the 
knockdown of Chaf1a/b was capable of rescuing the viral reporter, but not the knockdown 
of Rbbp4 (Figures S7A and S7B). Previous studies suggest that Rbbp4 complexes with 
Chaf1a/b in G1 phase. Notably, the epigenetic modification brought about by Chaf1a 
through HP1 or Caf1/Mbd1/Eset is S-phase-specific (Quivy et al., 2004; Sarraf and 
Stancheva, 2004).
How does a histone chaperone like Chaf1a localize to the proviral LTR and ERVs? Previous 
work has localized histone chaperones such as Hira and Daxx to the genomic sites where 
histones are deposited (Banaszynski et al., 2013; Elsässer et al., 2012). A recent publication 
also described the role of histone variants H3.3 in regulating ERVs (Elsässer et al., 2015). 
Indeed, our Chaf1a ChIP-seq shows the enrichment of Chaf1a at the genomic sites of 
downstream ERV targets. When we knockdown the upstream histone chaperones of Chaf1a 
(Asf1a/b), we observed the abolishment of the viral silencing effect of Chaf1a. Thus, we 
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speculate that its nucleosome assembly function may play a role in localizing Chaf1a to the 
integrated proviruses.
In conclusion, our work reveals the genome-wide compendium of players that mediate 
proviral silencing in mouse ESCs. Multiple pathways and multi-layered machineries are 
employed by pluripotent embryonic stem cells to maintain the silencing of proviruses and 
ERVs. Further studies aimed at dissecting the intricate mechanisms by which the various 
factors act will help fill the remaining gap in our understanding of proviral repression.
EXPERIMENTAL PROCEDURES
Genome-wide siRNA Screen
F9 cells were seeded at 6 × 105/well in 6-well tissue culture plates. Twelve hours later, 
MMLV virus was added into the wells with 8 mg/ml polybrene (107689, Sigma). Eight 
hours later, F9 cells were trypsinized into single cells and seeded onto individual well of 
384-well plates (REF 781091, Greiner) that were pre-printed with Mouse siGENOME 
SMARTpool library (G-015000, Thermo Scientific Dharmacon) and contain DharmaFECT 
1 (Thermo Scientific). Four days later, cells were fixed with 4% paraformaldehyde and cell 
nuclei were stained with Hoechst 33342 (Invitrogen). Images were acquired using the 
ImageXpress Ultra Confocal High Content Screening System (Molecular Devices). Gfp 
signal was quantified by the MetaXpress software (Molecular Devices). Both the siRNA 
screens were carried out in duplicates. The average of the duplicate Gfp signal was 
calculated by normalizing to both positive and negative controls using ScreenSifter software 
(Kumar et al., 2013). A cut-off threshold was set at value >2 SD from mean of negative 
controls, above which siRNA of 650 candidate genes significantly increase Gfp expression 
level. Based on the secondary screening, 303 high-confidence hits with Gfp signal 
(CtrlNorm value = (X − Avg(xcn))/(Avg(xcp) − Avg(xcn)) cut off above 0.45 were selected.
RNA-Sequencing
Total RNA was extracted as described in the Supplemental Experimental Procedures. DNA 
contamination was removed using a QIAGEN RNeasy Kit. The RNA samples were subject 
to mRNA selection, fragmentation, cDNA synthesis, and library preparation using a TruSeq 
RNA Sample Prep Kit (RS-122-2001, Illumina). Library quality was analyzed on a 
Bioanalyzer. High-throughput sequencing was performed on the Genome Analyzer IIx 
(Illumina).
ChIP and ChIP-Seq Assay
Chromatin was prepared according to the methods provided in the Supplemental 
Experimental Procedures. Chromatin extracts were immunoprecipitated using H3K4me3 
(Abcam), H3Ac (Abcam), H3K9me3 (Abcam), Eset (Abcam), Trim28 (Bethyl), Sumo2 
(Abcam), and HA (Santa Cruz) antibodies. Input and immunoprecipitation samples were 
analyzed by qPCR. All primers used are listed in Table S7. ChIP-seq libraries were prepared 
according to manufacturer’s instructions (Illumina). High-throughput sequencing was 
performed on a Genome Analyzer IIx (Illumina).
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Bioinformatics Analysis
See detailed information in the Supplemental Experimental Procedures.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Highlights
• Genome-wide siRNA screen identifies key determinants for proviral silencing in 
ESCs
• Histone chaperones, sumoylation factors, and chromatin modifiers can repress 
ERVs
• Sumo2 orchestrates viral silencing through sumoylation modification of Trim28
• Chaf1a regulates provirus and ERVs via its interaction with Eset, Kdm1a, and 
Hdac1/2
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Figure 1. Genome-wide siRNA Screen for Regulators of Proviral Silencing in Mouse F9 ECs
(A) Schematic of the proviral MMLV-Gfp reporter assay. The map of the proviral reporter is 
shown (upper panel). LTR (black) indicates the long terminal repeats, while PBS (blue) 
represents the primer binding site. F9 cells were infected with the reporter virus and 
subjected to reverse transfection with the siRNA library in 384-well plates. A representative 
image for Gfp fluorescence (green) and nuclear Hoechst 33342 staining (blue) in a 384-well 
plate is shown. In each 384-well plate, non-targeting siRNA control (siNT) and positive 
control siRNA against Trim28 and Eset (siTrim28 and siEset) were added.
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(B) Dot plot for genome-wide siRNA screen. A cut-off threshold was set at 0.37 (dotted 
line). Candidate genes above the threshold showed significant Gfp reactivation.
(C) Representative images of Gfp rescue for selected hits from the genome-wide screen. Gfp 
(green) and Hoechst 33342 staining of the nucleus (blue) are shown.
(D) Secondary siRNA screen for 74 genes. Results for reactivation of proviral Gfp or 
mCherry reporters are shown as heatmaps. Intensity of green or red color represents the 
level of reactivation of Gfp and mCherry reporters respectively. See Supplemental 
Experimental Procedures for details on the gene selection criteria and experimental design.
(E) Validation of candidate genes using shRNA knockdown. Gfp signal was detected by 
FACS. The percentage of Gfp activation is shown on the y axis. Values are mean ± SEM 
from independent replicate experiments.
See also Figure S1 and Table S1.
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Figure 2. Bioinformatics Analyses for the Genome-wide siRNA Screen and the ESC Specificity of 
the Candidate Genes
(A) Interactome analysis. Cellular localization of the hits is indicated.
(B) Interactions observed in hits of different ranking tiers. Localization of hits is indicated as 
in (A). P values and number of interactions are indicated.
(C and D) Validation of MMLV-Gfp rescue by siRNA knockdown of the top candidates in 
D3 and E14 ESCs. Non-targeting siRNA (siNT) and siRNA targeting non-hits (Dmnt1, 
Ehmt2, Senp7) were selected as controls. (C) Representative images of Gfp rescue by siRNA 
Yang et al. Page 21
Cell. Author manuscript; available in PMC 2015 December 21.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
knockdown of the indicated hits. Gfp (green) and Hoechst 33342 nucleus staining (blue) are 
shown. (D) Bar chart graphs for Gfp activation. Relative Gfp signal is shown on the y axis. 
Values are mean ± SEM from independent replicate experiments.
(E) Representative images of MMLV-mCherry and MMLV-Gfp rescue by siRNA 
knockdown of selected top hits in MEF and 3T3 cells. mCherry (red), Gfp (green) and 
Hoechst 33342 nucleus staining (blue) are shown.
(F) Representative images for Oct4 and Nestin staining on E14 cells (upper panel) and E14 
ESCs derived differentiated neural cells (lower panel).
(G) MMLV-Gfp rescue in E14-derived neural cells by siRNA knockdown of selected top 
hits. Relative Gfp signal is shown on the y axis. Values are mean ± SEM from independent 
replicate experiments.
See also Figure S2 and Table S2.
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Figure 3. Histone Modifiers and Sumoylation Factors Regulate ERVs in Mouse Embryonic Stem 
Cells
(A) Frequency histogram of gene expression from RNA-seq data after Chaf1a, Sumo2, 
Trim28, or Eset depletion in E14 cells. Log2 fold change of expression levels is shown on 
the x axis. The number of genes at a given expression level is shown on the y axis.
(B) Percentage stacked columns indicating the up or downregulation of ERVs upon the 
depletion of the indicated factors.
(C) Percentage stacked columns indicating the classes of upregulated ERVs upon the 
depletion of the indicated factors.
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(D) Clustering analysis of the indicated RNA-Seq libraries based on differential ERV 
expression. Heatmap color intensity signifies the correlation strength between 0 (red-high 
similarity) to 0.8 (yellow-high difference).
(E and F) Genome-wide de-regulation of ERVs in E14 cells after depletion of the indicated 
genes. RNA-seq data for RNAi samples and the shVector control were used to calculate the 
Log2 fold change values. Red dots indicate the elements with significantly increased 
expression.
(G and H) Venn diagrams demonstrating the number of commonly and differentially 
upregulated ERVs among the depletion of indicated factors.
See also Figure S3 and Table S3.
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Figure 4. Direct Recruitment of Chaf1a and Sumo2 to Genomic ERVs
(A) Heatmap indicating the recruitment of Sumo2, Trim28, Zfp809, and Chaf1a on the 
indicated ERVs of different classes (I–III) and Line/Sine elements (LS). ChIP-seq was 
performed for the indicated factors, Smad3 is used as a control. Red indicates binding 
whereas black indicates the absence of binding.
(B) Heatmaps of Chaf1a enrichment at the genomic regions flanking MER67C and 
MMERVK10c-int (left panels) and Sumo2 enrichment at the genomic regions flanking 
RLTR6 and ETnERV3-int (right panels).
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(C) Heatmaps of histone modifications at the genomic regions of the ERV loci bound by 
Chaf1a, Sumo2, Trim28, and Zfp809. The heatmaps are clustered according to the 
enrichment profile of H3K4me3.
(D) Enrichment of several histone marks at the genomic regions of the non-ERV loci that 
are bound by indicated factors. The reads in the heatmaps are clustered according to the 
enrichment profile of H3K4me3.
(E and F) Venn diagrams demonstrating the number of commonly and uniquely-bound ERV 
loci among the indicated factors. Percentage values indicate uniquely bound sites.
(G) UCSC genome browser screenshots. Chaf1a, Sumo2, Trim28, and Zfp809 bind 
eTnERV3-int-ERVK, while IAP-d-int/ERVK is bound specifically by Sumo2 and Trim28. 
Both ERVs are enriched with H3K9me3.
(H) Clustering analysis of the ERVs bound by the indicated factors. The color intensity 
signifies strength of correlation. Red indicates strong correlation, whereas yellow indicates 
weak correlation.
See also Figure S4 and Table S4.
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Figure 5. Sumo2 Regulates Proviruses by Post-translational Modification of Trim28
(A) Venn diagrams demonstrating the number of common and uniquely-bound ERV loci 
among the indicated factors. Sumo2 interacts extensively with the factors from the canonical 
pathway. Percentage values indicate uniquely bound sites.
(B–D) Sumo2 functions through Trim28 in proviral silencing. Sumo2 and Trim28 ChIP 
experiments were conducted on the samples with depletion of Sumo2 or Trim28. The 
enrichment was measured by qPCR. Data is presented as mean ± SEM from independent 
replicate experiments.
(E) Trim28 is modified by Sumo2 in vivo. A 3xFlag tag was added to the 5′ end of Sumo2 
genomic region using CRISPR/Cas in E14 cells. Two homozygous lines were selected for 
the immunoprecipitation assays. NEM was added to protect the sumoylated proteins from 
desumoylation by SENPs in the cell lysates.
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(F) Venn diagrams demonstrating the number of common and uniquely-bound ERV loci 
among indicated factors. The majority of the Trim28/H3K9me3 enriched ERVs are also 
bound by Sumo2. Percentage values indicate uniquely-bound sites.
(G and H) Knockdown of Sumo2 and Trim28 significantly reduced the H3K9me3 
enrichment on proviral PBS and ERVs. H3K9me3 ChIP was performed on the samples with 
depletion of Sumo2 or Trim28. Data is presented as mean ± SEM from independent replicate 
experiments.
(I) Knockdown of Trim28 and Sumo2 increased the active H3K4me3 mark on proviral 
elements. H3K4me3 ChIP was performed on samples with depleted Sumo2 or Trim28. Data 
is presented as mean ± SEM from independent replicate experiments.
See also Figure S5.
Yang et al. Page 28
Cell. Author manuscript; available in PMC 2015 December 21.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Figure 6. Differential Regulation of Class I, II, and III ERVs by Chaf1a
(A) Venn diagrams demonstrating the number of common and uniquely-bound ERV loci 
among Chaf1a, Trim28, and H3K9me3. Percentage values indicate uniquely-bound ERVs.
(B) Percentage stacked columns demonstrating the classes of ERVs bound by the indicated 
categories on the x axis.
(C) The correlation between the upregulation of the different classes of ERVs upon Chaf1a 
depletion and the enrichment of H3K9me3 mark. The data is plotted using shChaf1a RNA-
seq and H3K9me3 ChIP-seq. Grey, orange, and yellow dots represent ERVs with 
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significantly increased expression in class I, II, and III, respectively. Black dots indicate the 
non-regulated ERVs.
(D) Average binding profiles of the individual categories shows that ERVs belonging to the 
Chaf1a only and Chaf1a+Trim28 categories are highly enriched with Kdm1a and Hdac2 in 
comparison to the other categories.
(E) Enrichment of H3K9me3, Kdm1a, and Hdac2 in the genomic regions of the indicated 
categories. The reads in the heatmaps are clustered according to the enrichment profile of 
H3K9me3.
(F) UCSC genome browser screenshots of representative repeat elements. RMER16-int 
bound by Chaf1a and Trim28 is highly enriched with H3K9me3. In contrast, ORR1B2 is 
bound by Chaf1a, Trim28, Hdac2, and Kdm1a with very low H3K9me3 enrichment. 
Chaf1a, Hdac2, and Kdm1a bind RLTR11B with the absence of Trim28 and H3K9me3, 
while LTRIS5 is bound exclusively by Trim28.
See also Figure S6 and Table S5.
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Figure 7. Chaf1a Are Enriched at Proviruses and Regulates Their Expression through Its 
Interacting Epigenetic Co-factors
(A) SILAC mass spectrometry (MS) analysis uncovers the Chaf1a interactome network. 
Upper panel: schematic representation of the SILAC MS work-flow as described in the 
supplemental procedures. Lower panel: differential protein identification in Flag-tagged 
Chaf1a immunoprecipitation. Several epigenetic and chromatin regulators are indicated.
(B–D) Western blots confirm the interacting proteins identified by MS. Western blots 
showing co-immunoprecipitation (coIP) of Chaf1a with Eset, Kdm1a, and Hdac2.
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(E) Chaf1a is enriched at the proviral elements. Chaf1a-3xHA ChIP was carried out in F9 
Chaf1a-3xHA cell line using a HA antibody. The enrichment was analyzed by qPCR. Data 
are presented as mean ± SEM from independent replicate experiments.
(F and G) Localization of Kdm1a and Hdac2 on proviral DNA. ChIP was performed using 
antibodies against Kdm1a or Hdac2 and the enrichment was tested by qPCR.
(H–J) The perturbation of histone mark enrichment on proviral elements upon the depletion 
of Chaf1a in F9 cells. H3K9me3, H3K4me3, and H3Ac ChIP were performed on the 
samples upon depletion of Chaf1a. Data are presented as mean ± SEM from independent 
replicate experiments.
(K) Schematic model for the silencing mechanism of the proviruses in mESCs involving 
Chaf1a, Sumo2, and the canonical Zfp809/Trim28/Eset pathway. Chaf1a and its upstream 
histone chaperones Asf1a/b promote the deposition of histone H3/H4 to mark the integrated 
proviral DNA. Transcriptional repression of the proviral chromatin is reinforced by the 
enzymatic activities of Chaf1a-interacting proteins, including the members of the NuRD 
complex (Kdm1a, Hdac1/2) and Eset. This results in reduced acquisition of activating 
H3K4me3 and H3Ac marks. In parallel, Sumo2 sumoylates Trim28, which is necessary for 
recruiting Trim28 onto the proviral DNA, in turn resulting in the deposition of the repressive 
H3K9me3 mark.
See also Figure S7 and Table S6.
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